CONGRESSES

Our medical oncologists and laboratory investigators are regular speakers and organizers of some of the most important international seminars and scientific meetings.

We have presented the results of our investigations into the causes of cancer and novel treatments at some of the most important national and international oncology congresses.

BROWSE CONGRESSES
BY YEAR

Actualización en Cáncer de Páncreas 2018

DATE15/06/2018 - 15/06/2018

PLACEHospital Universitari Sagrat Cor (Barcelona)


  • Epidemiologia y manejo general del cáncer de páncreas

  • Cáncer de páncreas resecable

  • Novel therapies for advance pancreatic adenocarcinoma

  • Integración de QT y SBRT en el tratamiento del cáncer de páncreas localmente avanzado

  • Neuroendocrine pancreatic tumors


IX Symposium GEM

DATE15/06/2018 - 16/06/2018

PLACEPalacio de Congresos, Palma de Mallorca


  • Biopsia líquida:una herramienta para la estratificación de riesgo de recurrencia en estadios tempranos

    Dra. Niki Karachaliou. Hospital Universitari Quirón-Dexeus, Barcelona.

  • Factores moleculares relacionados con el pronóstico

    Dra. María González Cao. Hospital Universitario Dexeus, Barcelona.


FDA-IASLC Workshop on Neoadjuvant Therapy in Lung Cancers

DATE01/03/2018 - 02/03/2018

PLACEBethesda, USA

Biological Considerations for Neoadjuvant Therapies in Lung Cancers Rosell R

Mini Keynote Symposium on Translational Research. Primers in Cancer

DATE14/12/2017

PLACEInstitut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain

BRAFV600E& BRAF-inactivating mutations in NSCLC: Approaches to suppress the evolution to resistance Rosell R



 
[return] MELK signaling (maternal embryonic leucine kinase) & cell cycle Rosell R

Why is afatinib better than other EGFR TKIs? Rosell R

Combinations with CDK4/6 inhibitors in KRAS NSCLC Rosell R

FAK, CDCP1 and AXL in KRAS Rosell R

PARP inhibition, WEE1 kinase & AXL inhibitors in several types of cancer Rosell R

Snapshot of immunotherapy - CDK4/6 inhibitors & afatinib as enhancers of immune checkpoint inhibitors Rosell R

Spanish Lung Cancer Group Annual Congress

DATE16/11/2017 - 17/11/2017

PLACEBarcelona, Spain

New drugs design Rosell R